603718 海利生物
2025/09 - 九个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)1.31412.3265.33411.3345.219
总资产报酬率 ROA (%)1.1209.8253.9647.2422.967
投入资产回报率 ROIC (%)1.28311.8545.05110.7935.012

边际利润分析
销售毛利率 (%)74.10660.20451.39458.96955.767
营业利润率 (%)29.41664.39122.91923.30916.482
息税前利润/营业总收入 (%)26.71974.19724.41746.49319.928
净利润/营业总收入 (%)25.12567.01420.77636.89813.149

收益指标分析
经营活动净收益/利润总额(%)91.29414.352-12.3666.49734.243
价值变动净收益/利润总额(%)7.00369.982101.0728.61562.819
营业外收支净额/利润总额(%)-0.25516.1401.52146.711-0.179

偿债能力分析
流动比率 (X)7.6336.9011.3492.0731.456
速动比率 (X)6.9176.3521.1021.6221.243
资产负债率 (%)5.8766.76829.13326.63046.467
带息债务/全部投入资本 (%)1.0970.8430.619-2.041-13.039
股东权益/带息债务 (%)8,899.82911,585.74115,234.977-4,661.548-731.025
股东权益/负债合计 (%)1,447.6401,262.056251.985282.786117.354
利息保障倍数 (X)-10.192-28.67421.34416.8895.735

营运能力分析
应收账款周转天数 (天)194.939128.418136.280112.32577.648
存货周转天数 (天)404.904263.391381.076420.438302.978